Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Amortization of Deferred Charges (2024 - 2026)

Achieve Life Sciences (ACHV) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $12000.0 as the latest value for Q1 2026.

  • Quarterly Amortization of Deferred Charges fell 14.29% to $12000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $50000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $52000.0 for FY2025, 126.09% up from the prior year.
  • Amortization of Deferred Charges for Q1 2026 was $12000.0 at Achieve Life Sciences, up from $11000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $14000.0 in Q4 2024, with the low at $11000.0 in Q4 2025.
  • Average Amortization of Deferred Charges over 3 years is $13000.0, with a median of $13500.0 recorded in 2024.
  • The sharpest move saw Amortization of Deferred Charges fell 21.43% in 2025, then dropped 14.29% in 2026.
  • Achieve Life Sciences' Amortization of Deferred Charges stood at $14000.0 in 2024, then fell by 21.43% to $11000.0 in 2025, then increased by 9.09% to $12000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Amortization of Deferred Charges are $12000.0 (Q1 2026), $11000.0 (Q4 2025), and $13000.0 (Q3 2025).